Cargando…

Characterization of TET and IDH gene expression in chronic lymphocytic leukemia: comparison with normal B cells and prognostic significance

BACKGROUND: Chronic lymphocytic leukemia (CLL) is the most common hematological malignancy in western countries, characterized by a heterogeneous clinical course. Although genetic studies have identified chromosomal aberrations or specific mutations, epigenetic changes have been poorly characterized...

Descripción completa

Detalles Bibliográficos
Autores principales: Van Damme, Michaël, Crompot, Emerence, Meuleman, Nathalie, Maerevoet, Marie, Mineur, Philippe, Bron, Dominique, Lagneaux, Laurence, Stamatopoulos, Basile
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5141649/
https://www.ncbi.nlm.nih.gov/pubmed/27980696
http://dx.doi.org/10.1186/s13148-016-0298-y
_version_ 1782472653696663552
author Van Damme, Michaël
Crompot, Emerence
Meuleman, Nathalie
Maerevoet, Marie
Mineur, Philippe
Bron, Dominique
Lagneaux, Laurence
Stamatopoulos, Basile
author_facet Van Damme, Michaël
Crompot, Emerence
Meuleman, Nathalie
Maerevoet, Marie
Mineur, Philippe
Bron, Dominique
Lagneaux, Laurence
Stamatopoulos, Basile
author_sort Van Damme, Michaël
collection PubMed
description BACKGROUND: Chronic lymphocytic leukemia (CLL) is the most common hematological malignancy in western countries, characterized by a heterogeneous clinical course. Although genetic studies have identified chromosomal aberrations or specific mutations, epigenetic changes have been poorly characterized in CLL. METHODS: We assessed ten-eleven translocations (TET) 1, 2, and 3, isocitrate dehydrogenase (IDH) 1, and 2 messenger RNA (mRNA) expression using real-time PCR on purified leukemic B cells from 214 CLL patients (median follow-up = 75 months, range 1–380), normal peripheral blood B cells (n = 20), and umbilical cord blood B cells (n = 21). The microenvironment influence was assessed after 24 h co-culture of CLL cells with bone marrow mesenchymal stromal cells (BMSC). Finally, 5-hydroxymethylcytosine level (%5-hmC) was assessed by ELISA in CLL cells alone or with microenvironment stimuli. RESULTS: TET 1 and 3 and IDH2 were decreased in CLL cells compared with healthy B cells (P = 0.0221, 0.0013, <0.0001, respectively), while IDH1 was overexpressed (P = 0.0037). TET2 and IDH1 were significantly correlated with treatment-free survival (TFS); patients with high TET2/IDH1 expression had a higher median TFS (111 months) than patients with low expression (78 months, P = 0.0071/0.0123). Moreover, TET1 expression decreased (P = 0.0371), while TET3 and IDH2 expression increased (P = 0.0273/0.0039) in co-cultures. However, %5-hmC was not correlated with clinical data and was unchanged following microenvironment stimuli. CONCLUSIONS: Despite a slight deregulation in CLL cells compared with normal B cells, we identified a significant association between TET/IDH gene expression and prognosis, suggesting that epigenetic changes could potentially be associated with disease progression. Moreover, despite an identical %5-hmC, TET gene expression was influenced by contact with BMSC confirming the crucial role of the microenvironment in CLL pathogenesis. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13148-016-0298-y) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5141649
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-51416492016-12-15 Characterization of TET and IDH gene expression in chronic lymphocytic leukemia: comparison with normal B cells and prognostic significance Van Damme, Michaël Crompot, Emerence Meuleman, Nathalie Maerevoet, Marie Mineur, Philippe Bron, Dominique Lagneaux, Laurence Stamatopoulos, Basile Clin Epigenetics Research BACKGROUND: Chronic lymphocytic leukemia (CLL) is the most common hematological malignancy in western countries, characterized by a heterogeneous clinical course. Although genetic studies have identified chromosomal aberrations or specific mutations, epigenetic changes have been poorly characterized in CLL. METHODS: We assessed ten-eleven translocations (TET) 1, 2, and 3, isocitrate dehydrogenase (IDH) 1, and 2 messenger RNA (mRNA) expression using real-time PCR on purified leukemic B cells from 214 CLL patients (median follow-up = 75 months, range 1–380), normal peripheral blood B cells (n = 20), and umbilical cord blood B cells (n = 21). The microenvironment influence was assessed after 24 h co-culture of CLL cells with bone marrow mesenchymal stromal cells (BMSC). Finally, 5-hydroxymethylcytosine level (%5-hmC) was assessed by ELISA in CLL cells alone or with microenvironment stimuli. RESULTS: TET 1 and 3 and IDH2 were decreased in CLL cells compared with healthy B cells (P = 0.0221, 0.0013, <0.0001, respectively), while IDH1 was overexpressed (P = 0.0037). TET2 and IDH1 were significantly correlated with treatment-free survival (TFS); patients with high TET2/IDH1 expression had a higher median TFS (111 months) than patients with low expression (78 months, P = 0.0071/0.0123). Moreover, TET1 expression decreased (P = 0.0371), while TET3 and IDH2 expression increased (P = 0.0273/0.0039) in co-cultures. However, %5-hmC was not correlated with clinical data and was unchanged following microenvironment stimuli. CONCLUSIONS: Despite a slight deregulation in CLL cells compared with normal B cells, we identified a significant association between TET/IDH gene expression and prognosis, suggesting that epigenetic changes could potentially be associated with disease progression. Moreover, despite an identical %5-hmC, TET gene expression was influenced by contact with BMSC confirming the crucial role of the microenvironment in CLL pathogenesis. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13148-016-0298-y) contains supplementary material, which is available to authorized users. BioMed Central 2016-12-07 /pmc/articles/PMC5141649/ /pubmed/27980696 http://dx.doi.org/10.1186/s13148-016-0298-y Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Van Damme, Michaël
Crompot, Emerence
Meuleman, Nathalie
Maerevoet, Marie
Mineur, Philippe
Bron, Dominique
Lagneaux, Laurence
Stamatopoulos, Basile
Characterization of TET and IDH gene expression in chronic lymphocytic leukemia: comparison with normal B cells and prognostic significance
title Characterization of TET and IDH gene expression in chronic lymphocytic leukemia: comparison with normal B cells and prognostic significance
title_full Characterization of TET and IDH gene expression in chronic lymphocytic leukemia: comparison with normal B cells and prognostic significance
title_fullStr Characterization of TET and IDH gene expression in chronic lymphocytic leukemia: comparison with normal B cells and prognostic significance
title_full_unstemmed Characterization of TET and IDH gene expression in chronic lymphocytic leukemia: comparison with normal B cells and prognostic significance
title_short Characterization of TET and IDH gene expression in chronic lymphocytic leukemia: comparison with normal B cells and prognostic significance
title_sort characterization of tet and idh gene expression in chronic lymphocytic leukemia: comparison with normal b cells and prognostic significance
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5141649/
https://www.ncbi.nlm.nih.gov/pubmed/27980696
http://dx.doi.org/10.1186/s13148-016-0298-y
work_keys_str_mv AT vandammemichael characterizationoftetandidhgeneexpressioninchroniclymphocyticleukemiacomparisonwithnormalbcellsandprognosticsignificance
AT crompotemerence characterizationoftetandidhgeneexpressioninchroniclymphocyticleukemiacomparisonwithnormalbcellsandprognosticsignificance
AT meulemannathalie characterizationoftetandidhgeneexpressioninchroniclymphocyticleukemiacomparisonwithnormalbcellsandprognosticsignificance
AT maerevoetmarie characterizationoftetandidhgeneexpressioninchroniclymphocyticleukemiacomparisonwithnormalbcellsandprognosticsignificance
AT mineurphilippe characterizationoftetandidhgeneexpressioninchroniclymphocyticleukemiacomparisonwithnormalbcellsandprognosticsignificance
AT brondominique characterizationoftetandidhgeneexpressioninchroniclymphocyticleukemiacomparisonwithnormalbcellsandprognosticsignificance
AT lagneauxlaurence characterizationoftetandidhgeneexpressioninchroniclymphocyticleukemiacomparisonwithnormalbcellsandprognosticsignificance
AT stamatopoulosbasile characterizationoftetandidhgeneexpressioninchroniclymphocyticleukemiacomparisonwithnormalbcellsandprognosticsignificance